Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain

OBJECTIVES: This study estimated the cost of prophylaxis with activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa) in surgical patients with haemophilia A and inhibitors in Spain. METHODS: A decision‐analytic model was developed to estimate the cost to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mareque, María, Mingot‐Castellano, María Eva, López‐Fernández, María Fernanda, Álvarez‐Román, María Teresa, Oyagüez, Itziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383573/
https://www.ncbi.nlm.nih.gov/pubmed/32220097
http://dx.doi.org/10.1111/ejh.13414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383573/
https://www.ncbi.nlm.nih.gov/pubmed/32220097
http://dx.doi.org/10.1111/ejh.13414

Ejemplares similares